These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 467489)

  • 1. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML; Domzig W; Taskov H
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell.
    Domzig W; Lohmann-Matthes ML
    Eur J Immunol; 1979 Apr; 9(4):267-72. PubMed ID: 467490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promonocytes have the functional characteristics of natural killer cells.
    Lohmann-Matthes ML; Domzig W; Roder J
    J Immunol; 1979 Oct; 123(4):1883-6. PubMed ID: 479604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
    Meerpohl HG; Lohmann-Matthes ML; Fischer H
    Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
    Kohl S; Cahall DL; Walters DL; Schaffner VE
    J Immunol; 1979 Jul; 123(1):25-30. PubMed ID: 448149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow.
    van der Meer JW; van de Gevel JS; van Furth R
    J Reticuloendothel Soc; 1983 Sep; 34(3):203-25. PubMed ID: 6620253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS; Hodes RJ
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCC mediated by non-adherent mononuclear and polymorphonuclear cells of the guinea-pig.
    Hopkins SJ; Dale MM
    Immunology; 1980 Aug; 40(4):513-9. PubMed ID: 7429541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous cytotoxic T cells in murine spleen-cell cultures. I. Some characteristics of effector and precursor cells.
    Ezaki T; Skinner MA; Marbrook J
    Immunology; 1983 Nov; 50(3):343-9. PubMed ID: 6605301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.